Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and butorphanol during intracranial hematoma evacuation
ChiCTR1900025962Phase 4Not yet recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and butorphanol in intracerebral hemorrhage (ICH) and brain hemorrhage (ICH) (4 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Glasgow Coma Score, Inflammatory factors in plasma and 2 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
dexmedetomidinebutorphanol
03
Conditions
intracerebral hemorrhage (ICH)brain hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR1900025962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025962.